Erenumab effective, safe for rosacea-linked erythema, flushing

The anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published in JAMA Dermatology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup